Exact Mass: 308.0160338
Exact Mass Matches: 308.0160338
Found 196 metabolites which its exact mass value is equals to given mass value 308.0160338,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2'-Deoxyuridine 5'-monophosphate disodium salt
Deoxyuridine monophosphate (dUMP), also known as deoxyuridylic acid or deoxyuridylate in its conjugate acid and conjugate base forms, respectively, is a deoxynucleotide. It belongs to the class of organic compounds known as pyrimidine 2-deoxyribonucleoside monophosphates. These are pyrimidine nucleotides with a monophosphate group linked to the ribose moiety lacking a hydroxyl group at position 2. dUMP exists in all living species, ranging from bacteria to humans. Within humans, dUMP participates in a number of enzymatic reactions. In particular, dUMP can be biosynthesized from dCMP through its interaction with the enzyme deoxycytidylate deaminase. In addition, dUMP can be biosynthesized from deoxyuridine; which is mediated by the enzyme thymidine kinase, cytosolic. In humans, dUMP is involved in pyrimidine metabolism. A pyrimidine 2-deoxyribonucleoside 5-monophosphate having uracil as the nucleobase. Outside of the human body, dUMP has been detected, but not quantified in several different foods, such as breadnut tree seeds, sea-buckthornberries, sour cherries, black walnuts, and common oregano. dUMP is formed by the reduction of ribonucleotides to deoxyribonucleotides by ribonucleoside diphosphate reductase [EC 1.17.4.1]. dUMP by the action of by thymidylate synthetase [EC 2.1.1.45] produces dTMP (5,10-Methylene-5,6,7,8-tetrahydrofolate is a cofactor for the reaction). The nuclear form of uracil-DNA glycosylase (UNG2), that its major role is to remove misincorporated dUMP residues (cells deficient in removal of misincorporated dUMP accumulate uracil residues). (PMID 11554311) [HMDB]. dUMP is found in many foods, some of which are ginger, evergreen huckleberry, vanilla, and common walnut. dUMP. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=964-26-1 (retrieved 2024-07-15) (CAS RN: 964-26-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
(R)-5-Diphosphomevalonic acid
Mevalonate-diphosphate, also known as 5-diphosphomevalonic acid or mevelonic acid-5-diphosphoric acid, is a member of the class of compounds known as organic pyrophosphates. Organic pyrophosphates are organic compounds containing the pyrophosphate oxoanion, with the structure OP([O-])(=O)OP(O)([O-])=O. Thus, mevalonate-diphosphate is considered to be a fatty acid lipid molecule. Mevalonate-diphosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Mevalonate-diphosphate can be found in a number of food items such as kohlrabi, enokitake, avocado, and redcurrant, which makes mevalonate-diphosphate a potential biomarker for the consumption of these food products. Mevalonate-diphosphate exists in all eukaryotes, ranging from yeast to humans. In humans, mevalonate-diphosphate is involved in several metabolic pathways, some of which include zoledronate action pathway, lovastatin action pathway, pamidronate action pathway, and desmosterolosis. Mevalonate-diphosphate is also involved in several metabolic disorders, some of which include wolman disease, lysosomal acid lipase deficiency (wolman disease), cholesteryl ester storage disease, and CHILD syndrome. 5-Diphosphomevalonic acid (CAS: 1492-08-6) is a metabolic intermediate in the mevalonate pathway, catalyzed by the enzyme phosphomevalonate kinase from 5-phosphomevalonate (Wikipedia).
FENSULFOTHION
CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8595; ORIGINAL_PRECURSOR_SCAN_NO 8592 CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8562; ORIGINAL_PRECURSOR_SCAN_NO 8559 CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8609; ORIGINAL_PRECURSOR_SCAN_NO 8605 CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8582; ORIGINAL_PRECURSOR_SCAN_NO 8581 CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8608; ORIGINAL_PRECURSOR_SCAN_NO 8606 CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8628; ORIGINAL_PRECURSOR_SCAN_NO 8627
Aplysinal
(R)-3,5-bisphosphomevalonic acid
(R)-Mevalonic acid-5-pyrophosphate
(R)-Mevalonic acid-5-pyrophosphate (mevalonate 5-diphosphate) is a directly synthesized product of mevalonate phosphate that is essential for cell proliferation. (PMID 2211719). It is a substrate for mevalonate-5-diphosphate decarboxylase, the third enzyme involved in the biosynthesis of cholesterol from mevalonic acid. This enzyme catalyzes the reaction of mevalonate 5-diphosphate (MVADP) with ATP to produce isopentenyl diphosphate, ADP, CO2, and inorganic phosphate. The overall reaction involves an anti elimination of the tertiary hydroxyl and carboxyl groups. This metabolite participates both in the biosynthesis of cholesterol and fatty acid mechanism, through which interpathway regulation could take place between the cholesterol and FA cascades. (PMID 8769113 ) [HMDB] (R)-Mevalonic acid-5-pyrophosphate (mevalonate 5-diphosphate) is a directly synthesized product of mevalonate phosphate that is essential for cell proliferation. (PMID 2211719). It is a substrate for mevalonate-5-diphosphate decarboxylase, the third enzyme involved in the biosynthesis of cholesterol from mevalonic acid. This enzyme catalyzes the reaction of mevalonate 5-diphosphate (MVADP) with ATP to produce isopentenyl diphosphate, ADP, CO2, and inorganic phosphate. The overall reaction involves an anti elimination of the tertiary hydroxyl and carboxyl groups. This metabolite participates both in the biosynthesis of cholesterol and fatty acid mechanism, through which interpathway regulation could take place between the cholesterol and FA cascades. (PMID 8769113 ).
cis-Resveratrol 3-sulfate
cis-Resveratrol 3-sulfate is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
cis-Resveratrol 4'-sulfate
cis-Resveratrol 4-sulfate is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Resveratrol 3-sulfate
Resveratrol 3-sulfate, also known as resveratrol 3-sulphuric acid, is a polyphenol metabolite detected in biological fluids [http://phenol-explorer.eu/] (PMID: 20428313). Resveratrol 3-sulfate is classified as a member of the Stilbenes. Stilbenes are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids. Resveratrol 3-sulfate can be found in human biolfuids (http://phenol-explorer.eu/). Within a cell, Resveratrol 3-sulfate is primarily located in the cytoplasm and in the extracellular space.
trans-Resveratrol 4'-sulfate
trans-Resveratrol 4-sulfate is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-YL)urea
Nimesulide
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
[(2S,5S)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate
Sulisobenzone
C1892 - Chemopreventive Agent > C851 - Sunscreen
Caraibical
nimesulide
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors CONFIDENCE standard compound; INTERNAL_ID 561; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4430; ORIGINAL_PRECURSOR_SCAN_NO 4429 CONFIDENCE standard compound; INTERNAL_ID 561; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4395; ORIGINAL_PRECURSOR_SCAN_NO 4394 CONFIDENCE standard compound; INTERNAL_ID 561; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4423; ORIGINAL_PRECURSOR_SCAN_NO 4422 CONFIDENCE standard compound; INTERNAL_ID 561; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4416; ORIGINAL_PRECURSOR_SCAN_NO 4414 CONFIDENCE standard compound; INTERNAL_ID 561; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4408; ORIGINAL_PRECURSOR_SCAN_NO 4406
Sulisobenzone
C1892 - Chemopreventive Agent > C851 - Sunscreen CONFIDENCE standard compound; INTERNAL_ID 260; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3788; ORIGINAL_PRECURSOR_SCAN_NO 3785 CONFIDENCE standard compound; INTERNAL_ID 260; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3786; ORIGINAL_PRECURSOR_SCAN_NO 3783 CONFIDENCE standard compound; INTERNAL_ID 260; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3807; ORIGINAL_PRECURSOR_SCAN_NO 3805 CONFIDENCE standard compound; INTERNAL_ID 260; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3851; ORIGINAL_PRECURSOR_SCAN_NO 3849 CONFIDENCE standard compound; INTERNAL_ID 260; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3796; ORIGINAL_PRECURSOR_SCAN_NO 3793
ascidiathiazone A
An organic heterotricyclic compound, that is 3,4-dihydro-2H-[1,4]thiazino[2,3-g]quinoline-5,10 dione S,S-dioxide substituted at position 7 by a carboxyl group. It is an anti-inflmmatory alkaloid obtained from Aplidium.
6,7-dihydroxy-3-(1-hydroxy-3-oxo-butyl)-4-oxo-chromene-5-carboxylic acid
1,3-Bis-(2-chlor-1,1,2-trifluor-aethoxy)-propan|1,3-bis-(2-chloro-1,1,2-trifluoro-ethoxy)-propane
1,2,3-Trihydroxy-6-methoxy-7-chloro-9H-xanthene-9-one
(E)-5-(1-Acetoxy-2-chloro-1-buten-3-ynyl)-2,2?脣-bithiophene
2-Acetonyl-6,7-dihydroxy-3-hydroxymethyl-4-oxo-4H-chromen-5-carbonsaeure|2-acetonyl-6,7-dihydroxy-3-hydroxymethyl-4-oxo-4H-chromene-5-carboxylic acid
8-bromoethoxypsoralen|9-(2-bromo-ethoxy)-furo[3,2-g]chromen-7-one|9-(2-bromoethoxy)-2H-furo[3,2-g]chromen-2-one|9-(2-bromoethoxy)-7H-furo[3,2-g]chromen-7-one
1,1,1-TRICHLORO-4-HYDROXY-11-METHYLDODECA-3,5,7,9-TETRAEN-2-ONE
Benzophenone-4
CONFIDENCE standard compound; INTERNAL_ID 2867 CONFIDENCE standard compound; INTERNAL_ID 8802 CONFIDENCE standard compound; INTERNAL_ID 8220 CONFIDENCE standard compound; INTERNAL_ID 4183 CONFIDENCE Reference Standard (Level 1)
dUMP
A pyrimidine 2-deoxyribonucleoside 5-monophosphate having uracil as the nucleobase.
3,7,8-trihydroxy-3-methyl-10-oxo-1,4-dihydropyrano[4,3-b]chromene-9-carboxylic acid
3-Bromo-4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzoic acid
C12H9BrN2O3 (307.97965039999997)
Pyrimido[4,5-g]quinazoline-4,9-dione,2-(chloromethyl)-1,6-dihydro-5,10-dihydroxy-7-methyl- (9CI)
C12H9ClN4O4 (308.03123039999997)
4-DIETHYLPHOSPHONO-(O-METHANESULFONYL)PHENOL
C11H17O6PS (308.04834320000003)
ETHYL 5-BROMO-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
Propanimidic acid,3,3-dithiobis-, 1,1-dimethyl ester, hydrochloride (1:2)
C8H18Cl2N2O2S2 (308.01867080000005)
4-BROMO-3-FLUORO-4-METHOXYBENZOPHENONE
C14H10BrFO2 (307.98481519999996)
2-phosphonobutane-1,2,4-tricarboxylic acid, potassium salt
C7H10KO9P (307.96995200000003)
5-bromo-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinonitrile
2-(3,5-dichlorophenoxy)-5-nitrobenzonitrile
C13H6Cl2N2O3 (307.97554660000003)
2-bromo-trans-beta-styrylboronic acid pinacol ester
ethyl 3-(4-bromophenyl)-1-methyl-1h-pyrazole-5-carboxylate
BOC-(1S,2R)-(+)-2-AMINOCYCLOHEX-4-ENE-CARBOXYLIC ACID
C14H10BrFO2 (307.98481519999996)
5-(4-bromophenyl)-1-(tetrahydro-2H-pyran-2-yl)tetrazole
3-CHLORO-6,11-DIHYDRO-5,5-DIOXO-11-AMINO-6-METHYLDIBENZO[C,F][1,2]THIAZEPINE
C14H13ClN2O2S (308.03862280000004)
ETHYL 2-(4-HYDROXY-3-NITROPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE
5-[3-(TRIFLUOROMETHYL)BENZYLTHIO]-1,3,4-THIADIA-ZOLE-2-THIOL
ETHYL 4-(4-CHLOROPHENYL)-5-CYANAMIDE-4,5-DIHYDRO-1,3,4-THIADIAZOLE-2-CARBOXYLATE
1-(3-Chlorophenyl)-4-(3-Chloropropyl)Piperazine Hydrochloride
C13H19Cl3N2 (308.06137440000003)
2-ACETYL-2H-INDAZOL-7-YL TRIFLUOROMETHANESULFONATE
C10H7F3N2O4S (308.00786180000006)
Benzene,1,1-[(1E)-1,2-ethenediylbis(sulfonyl)]bis-
Zinc Picolinate
C12H8N2O4Zn (307.97754979999996)
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3-[2-(2,4-Dichlorophenoxy)phenyl]acrylic acid
C15H10Cl2O3 (308.00069700000006)
1-benzoyl-3,5-bis(trifluoromethyl)pyrazole
C12H6F6N2O (308.03842979999996)
Nimustine HCL
C9H14Cl2N6O2 (308.05552439999997)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
(3-BOC-AMINO-PYRROLIDIN-1-YL)-(1H-INDOL-2-YL)-ACETICACID
6-amino-3-(2,6-dichlorophenyl)-1-methylpyrazolo[1,5-a]pyrimidin-2-one
Benzeneacetic acid,4-chloro-a-(4-chlorophenyl)-, ethyl ester
(5-Bromo-pyrimidin-2-yl)-(4-methyl-3-nitro-phenyl)-amine
4-bromo-trans-beta-styrylboronic acid pinacol ester
2-[(4-CHLOROPHENYL)THIO]-5-NITROBENZOIC ACID
C13H7ClNO4S- (307.97843120000005)
3-BENZYLOXY-6-BROMO-2-FLUOROBENZALDEHYDE
C14H10BrFO2 (307.98481519999996)
3-BROMO-3-FLUORO-4-METHOXYBENZOPHENONE
C14H10BrFO2 (307.98481519999996)
2-(4-Chlorophenyl)-3-(trifluoromethyl)pyrazole-4-carbonyl chloride
Methyl 4-((5-bromopyrimidin-2-yl)oxy)benzoate
C12H9BrN2O3 (307.97965039999997)
3-[(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-benzoic acid
N-(4,6-DIMETHYL-2-PYRIMIDINYL)-4-NITROBENZENESULFONAMIDE
4,5-Dichloro-2-(4-(trifluoromethyl)phenyl)pyridazin-3(2H)-one
5-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-2-FURALDEHYDE
C13H6F6O2 (308.02719679999996)
D-Gluco-2,5-anhydro-1-deoxy-1-phosphonohexitol-6-phosphate
Resveratrol-3-O-sulfate
An organic sulfate that is the 3-O-sulfate derivative of trans-resveratrol. D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D020011 - Protective Agents > D000975 - Antioxidants D004791 - Enzyme Inhibitors
4-hydroxy-7-methyl-9-phenylpyrido[2,3:4,5]thieno[2,3-b]pyridin-2(1H)-one
(S)-N-[3-(Trifluoromethyl)-4-nitrophenyl]-2-methyl-2,3-dihydroxypropionamide
4-(Aminosulfonyl)-N-[(4-fluorophenyl)methyl]-benzamide
N-[4-(2-pyrimidinylsulfamoyl)phenyl]carbamic acid methyl ester
S-(4-chlorophenyl) 3,4-dimethoxybenzenecarbothioate
C15H13ClO3S (308.02738980000004)
1-[2-(4-Chlorophenyl)ethyl]-3-(4-fluorophenyl)thiourea
C15H14ClFN2S (308.05502060000003)
5-(4-bromophenyl)-N-propan-2-yl-3-isoxazolecarboxamide
2-[(2-Chloro-4-nitroanilino)methyl]-6-methoxyphenol
3-(3-methylphenyl)-2-sulfanylidene-1H-benzofuro[3,2-d]pyrimidin-4-one
(E)-1-(2,4-dichlorophenyl)-3-(1,3,5-trimethylpyrazol-4-yl)prop-2-en-1-one
2-(2-imino-3-thiazolyl)-N-(2-methoxy-4-nitrophenyl)acetamide
(R)-5-Diphosphomevalonic acid
The 5-diphospho derivative of (R)-mevalonic acid.
(3S)-3-hydroxy-5-{[hydroxy(phosphonooxy)phosphoryl]oxy}-3-methylpentanoic acid
IC87201
IC87201, an inhibitor of PSD95-nNOS protein-protein interactions, suppresses NMDAR-dependent NO and cGMP formation.
TC-S 7009
TC-S 7009 is a potent and selective HIF-2α inhibitor with a Kd of 81 nM. TC-S 7009 is more selective for HIF-2α than HIF-1α (Kd ? 5 μM). TC-S 7009 disrupts HIF-2α heterodimerization, decreases DNA-binding activity, and reduces HIF-2α target gene expression[1][2].
3-chloro-6,8-dihydroxy-2,2-dimethyl-3h,4h-naphtho[2,3-b]pyran-5,10-dione
methyl 8,11-dihydroxy-3-methyl-7-oxo-2,4,9-trioxatricyclo[8.4.0.0³,⁸]tetradeca-1(14),5,10,12-tetraene-13-carboxylate
6,7-dihydroxy-4-oxo-3-(3-oxobutanoyl)-2,3-dihydro-1-benzopyran-5-carboxylic acid
7-chloro-1,2,3-trihydroxy-6-methoxyxanthone
{"Ingredient_id": "HBIN013134","Ingredient_name": "7-chloro-1,2,3-trihydroxy-6-methoxyxanthone","Alias": "NA","Ingredient_formula": "C14H9ClO6","Ingredient_Smile": "COC1=C(C=C2C(=C1)OC3=CC(=C(C(=C3C2=O)O)O)O)Cl","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3573","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,7,8-trihydroxy-3-methyl-10-oxo-1h,4h-pyrano[4,3-b]chromene-6-carboxylic acid
4,6,7-trihydroxy-3-(3-oxobutanoyl)-2h-chromene-5-carboxylic acid
methyl 2-chloro-1,8-dihydroxy-9-oxocyclopenta[b]chromene-1-carboxylate
4,4,5,10-tetraoxo-1h,2h,3h-4λ⁶-[1,4]thiazino[3,2-g]quinoline-7-carboxylic acid
6,7-dihydroxy-3-(1-hydroxy-3-oxobutyl)-4-oxochromene-5-carboxylic acid
8-chloro-7-(hexa-2,4-diyn-1-ylidene)-9-hydroxy-1,6-dioxaspiro[4.4]non-2-en-4-yl acetate
5-chloro-2-[3-(dichloromethylidene)hexyl]benzene-1,3-diol
(4r,5s,7e,8s,9r)-8-chloro-7-(hexa-2,4-diyn-1-ylidene)-9-hydroxy-1,6-dioxaspiro[4.4]non-2-en-4-yl acetate
(1r,11r)-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione
[(2r,3r,5r)-3-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxyphosphonic acid
(3s)-6,7-dihydroxy-3-[(1z)-1-hydroxy-3-oxobut-1-en-1-yl]-4-oxo-2,3-dihydro-1-benzopyran-5-carboxylic acid
(3r)-3-chloro-6,8-dihydroxy-2,2-dimethyl-3h,4h-naphtho[2,3-b]pyran-5,10-dione
8-amino-2-carbamoyl-7-chloro-n-methyl-5,6-dioxoquinoline-4-carboximidic acid
C12H9ClN4O4 (308.03123039999997)